What stage does Axil Capital invest at?

Axil Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.

What sectors does Axil Capital focus on?

Axil Capital focuses on Biotech, Digital Health, Medical Devices.

Where is Axil Capital located?

Axil Capital is headquartered in Tokyo, JP.

Axil Capital

Venture capital

Tokyo · Seed–Late Stage · 7 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Axil Capital

194 people in our graph share verified history with the Axil Capital team — schools, employers, funds. One of them is your warm intro.

Kazunori Yamaguchiunlockedknows Kimihito Usui · together at The University of Tokyo (overlapped)

×6knows the team · via The University of Tokyo

knows the team · via Tohoku University

×4knows the team · via Altamont Capital Partners

✨ Fox Verdict

Investment thesis

Axil Capital pursues a strategy of creating value in the life sciences venture ecosystem by identifying and nurturing transformational biotech and healthcare technologies across the full investment spectrum. The firm diversifies its portfolio across biopharmaceuticals, platform technologies, medical devices, digital health, and healthcare services. The investment thesis emphasizes establishing synergies between Japan's biotech ecosystem and global markets to build commercially viable enterprises with sustainable returns while addressing transformational needs in healthcare and medical innovation.

Invests inBiotech Digital Health Medical Devices Global Japan Tokyo

Source: firm website, verified Aug 5, 2026.

Stage

Seed–Late Stage

Tokyo, JP

Instruments

Equity

Founded

2017

Tracked investments

Team · 7 people

from the firm's website & public directories

Frederick Shane· Managing Partner· Tokyo

Hiroshi Gonaikawa· Partner· Japanin

Joon Paek· Principal

Kimihito Usui· Senior Principal· Japanin

Kimihito Usui is a Senior Principal at Axil Capital Partners (Axil Capital Advisors K.K.), focusing on early-stage biotech investment across the US, Japan, and Taiwan. He holds a Ph.D. in pharmaceutical sciences from the University of Tokyo and worked as a researcher on artificial cell models and later as a lead researcher at a drug discovery venture, where he handled preclinical study design, budget management, fundraising, and business development, publishing 12 peer-reviewed papers. Since 2016 he has worked in life science and healthcare investment, establishing his firm's first direct biotech investment scheme in a securities-based principal investment division and completing direct investments in nine companies across the US and Japan, two of which listed on NASDAQ.

Akihisa Seita· Principal· Tokyoin

Kenji Maekubo· Principal· Tokyoin

Yoshitake Maeda· Venture Partner

What they invest in

from 2 of 2 portfolio companies

AI & Machine Learning ×1Biotech ×1Digital Health ×1Medical Devices ×1

HQs:United States×1

Investments · 2 tracked

founders shown can be your intro path

Suono Biosuonobio.com inJul 2021

BiotechMedford, US

Giovanni Traverso(Director)inRobert Langer(Director)Carl Schoellhammer(Executive Officer, Director)inAmy Schulman(Director)

Co-investorsTaiwania Capital

TechsoMedtechsomed.com inMar 2021 · $7M

TechsoMed develops BioTrace, an FDA-cleared software platform for image-guided minimally invasive cancer therapy that uses AI to provide real-time 3D visualization, tumor margin control, needle path planning, and post-ablation tissue response prediction.

AI & Machine LearningDigital HealthMedical Devices

Co-investorsNextLeap Ventures

Frequently asked questions

What stage does Axil Capital invest at?: Axil Capital invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Axil Capital focus on?: Axil Capital focuses on Biotech, Digital Health, Medical Devices.
Where is Axil Capital located?: Axil Capital is headquartered in Tokyo, JP.

Images

Co-investors · 2

Astellas Venture Management LLC

Astellas Venture Management (AVM) is the wholly-owned corporate venture arm of Astellas, providing equity investments to private, early-stage biotechnology companies developing therapeutic programs and platform technologies for drug discovery.

$200K – $5M

Remiges Ventures, Inc.

Remiges Ventures is a venture capital firm focused on life sciences and drug discovery, backing biotech and therapeutics companies. It launched the RDiscovery Fund to incubate early-stage drug discovery projects.

Firms observed investing alongside Axil Capital, from public investor directories. Shared companies are the overlap with Axil Capital's recorded portfolio.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

Khosla Ventures

Khosla Ventures is a venture capital firm founded by Vinod Khosla.

$5K – $50M

Sofinnova Ventures

Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.

$100K – $15M

OrbiMed

OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.

$1M – $75M